Why is Transgene Biotek falling/rising?

As of 01-Jul, Transgene Biotek Ltd's stock price is currently at 4.59, reflecting a decrease of 0.01, or 0.22%. The stock has shown a mixed performance in recent periods, with a 1-week increase of 4.79% and a 1-month rise of 8.77%. However, it has significantly underperformed year-to-date, with a decline of 32.80%, and a substantial drop of 48.60% over the past year. Today's trading activity indicates that the stock is currently underperforming its sector by 0.27%. Notably, the delivery volume has surged by 338.78% compared to the 5-day average, suggesting increased investor participation. The stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but remains below the 200-day moving average, indicating a mixed technical outlook.
In the broader market context, Transgene Biotek's recent performance contrasts with the Sensex, which has gained 2.00% over the past week and 2.76% over the past month. While the stock has shown some short-term recovery, its long-term performance remains concerning, particularly with a year-to-date decline that starkly contrasts with the Sensex's positive return of 7.11%. The lack of available positive or negative factors further complicates the analysis of the stock's current trajectory, leaving a gap in understanding the specific catalysts for its recent price movement.